Clinical Trials Browser

Interventional × Ifosfamide × Head & Neck × Clear all

Nasopharyngeal Neoplasms

NCT00484601 2019-02-11

Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma

Phase 2 Terminated

9 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT00003657 2017-01-20

High-dose ICE With Amifostine

Phase 2 Completed

24 enrolled

CNSGenitourinaryGynecologicHead & NeckSarcomaThoracic

AIDS-related Kaposi sarcoma, Testicular Germ Cell Tumor, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Unknown Primary, Ovarian Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

Clinical Trials

Autologous Stem Cell Transplantation for Patients With Recurrent Nasopharyngeal Carcinoma

Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma

High-dose ICE With Amifostine